FLACC1

gene
On this page

Summary

FLACC1 (flagellum associated containing coiled-coil domains 1, HGNC:14439) is a protein-coding gene on chromosome 2q33.1, encoding Flagellum-associated coiled-coil domain-containing protein 1 (Q96Q35).

Predicted to be located in cytoplasmic vesicle and outer dense fiber. Predicted to be active in cytoplasm.

Source: NCBI Gene 130540 — RefSeq curated summary.

At a glance

  • GWAS associations: 17
  • Clinical variants (ClinVar): 80 total
  • MANE Select transcript: NM_001127391

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:14439
Approved symbolFLACC1
Nameflagellum associated containing coiled-coil domains 1
Location2q33.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000155749
Ensembl biotypeprotein_coding
OMIM619796
Entrez130540

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 7 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000286190, ENST00000392257, ENST00000405148, ENST00000415745, ENST00000418364, ENST00000425488, ENST00000439709, ENST00000448967, ENST00000494171, ENST00000494223

RefSeq mRNA: 3 — MANE Select: NM_001127391 NM_001127391, NM_001289993, NM_139163

CCDS: CCDS2346, CCDS46488

Canonical transcript exons

ENST00000392257 — 15 exons

ExonStartEnd
ENSE00001076302201288271201288781
ENSE00001511250201289696201289785
ENSE00003476532201289457201289566
ENSE00003497193201348254201348302
ENSE00003508276201342370201342431
ENSE00003535634201346542201346675
ENSE00003545149201309151201309250
ENSE00003546406201351292201351451
ENSE00003569041201344170201344263
ENSE00003570069201330736201330833
ENSE00003623865201350711201350782
ENSE00003624320201307519201307622
ENSE00003670033201299238201299300
ENSE00003679717201330470201330522
ENSE00003904935201356982201357345

Expression profiles

Bgee: expression breadth ubiquitous, 168 present calls, max score 96.25.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1696 / max 32.2510, expressed in 51 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
332190.142649
332200.02718

Top tissues by expression

248 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130296.25gold quality
bronchial epithelial cellCL:000232888.57gold quality
bronchusUBERON:000218586.42gold quality
mucosa of paranasal sinusUBERON:000503084.84gold quality
left testisUBERON:000453383.91gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.90gold quality
right testisUBERON:000453483.02gold quality
testisUBERON:000047381.41gold quality
olfactory segment of nasal mucosaUBERON:000538679.92gold quality
descending thoracic aortaUBERON:000234577.71gold quality
cardiac muscle of right atriumUBERON:000337977.17gold quality
heart left ventricleUBERON:000208477.08gold quality
left ventricle myocardiumUBERON:000656677.05gold quality
ascending aortaUBERON:000149676.65gold quality
thoracic aortaUBERON:000151576.52gold quality
cardiac ventricleUBERON:000208276.38gold quality
calcaneal tendonUBERON:000370176.00gold quality
apex of heartUBERON:000209875.72gold quality
right atrium auricular regionUBERON:000663175.48gold quality
cardiac atriumUBERON:000208174.97gold quality
right lungUBERON:000216774.75gold quality
bone marrow cellCL:000209274.71gold quality
sural nerveUBERON:001548874.70gold quality
heartUBERON:000094874.53gold quality
aortaUBERON:000094774.21gold quality
fallopian tubeUBERON:000388973.35gold quality
left coronary arteryUBERON:000162672.95gold quality
lower esophagus muscularis layerUBERON:003583372.86gold quality
lower esophagusUBERON:001347372.79gold quality
popliteal arteryUBERON:000225072.73gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.87

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

18 targeting FLACC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-150-5P99.9966.691976
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-30A-3P99.8769.742928
HSA-MIR-30D-3P99.8769.922917
HSA-MIR-30E-3P99.8769.682942
HSA-MIR-58699.6570.402051
HSA-MIR-427699.5667.662514
HSA-MIR-186-3P99.5166.241685
HSA-MIR-513C-5P99.5068.421730
HSA-MIR-514B-5P99.5068.191766
HSA-MIR-4650-3P99.0168.391062
HSA-MIR-939-3P98.9765.072347
HSA-MIR-6501-3P98.7167.451480
HSA-MIR-676-5P98.4968.871492
HSA-MIR-6831-5P98.2667.20990
HSA-MIR-3927-3P97.6866.76892
HSA-MIR-5189-3P97.5266.33487
HSA-MIR-6736-3P96.9865.221342

Literature-anchored findings (GeneRIF, showing 2)

  • Genome-wide association studies show a significant association between the intronic SNP rs1830298 in ALS2CR12 gene and breast cancer; further expression studies suggest that CASP8 might be the target gene. (PMID:25168388)
  • rs13014235 is associated with susceptibility to cutaneous basal cell carcinoma. (PMID:25855136)

Cross-species orthologs

9 orthologs

OrganismSymbolGene ID
mus_musculusFlacc1ENSMUSG00000047528
rattus_norvegicusFlacc1ENSRNOG00000024917
caenorhabditis_elegansWBGENE00007131
caenorhabditis_elegansWBGENE00007132
caenorhabditis_elegansWBGENE00007134
caenorhabditis_eleganspals-3WBGENE00007657
caenorhabditis_eleganspals-5WBGENE00007659
caenorhabditis_eleganspals-6WBGENE00007660
caenorhabditis_eleganspals-13WBGENE00012505

Protein

Protein identifiers

Flagellum-associated coiled-coil domain-containing protein 1Q96Q35 (reviewed: Q96Q35)

Alternative names: Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein

All UniProt accessions (4): Q96Q35, C9JTY0, C9JZS0, H7C1T5

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Cytoplasm. Cytoplasmic granule. Cell projection. Cilium. Flagellum.

Isoforms (2)

UniProt IDNamesCanonical?
Q96Q35-11yes
Q96Q35-22

RefSeq proteins (3): NP_001120863, NP_001276922, NP_631902 (=MANE)

Domains & families (InterPro)

IDNameType
IPR026674FLACC1Family

UniProt features (9 total): coiled-coil region 3, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96Q35-F175.950.47

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 376

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 55 (showing top): GOCC_MOTILE_CILIUM, GOCC_CILIUM, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D, GOCC_OUTER_DENSE_FIBER, GOCC_9PLUS2_MOTILE_CILIUM, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, GOCC_SUPRAMOLECULAR_POLYMER, SRSF9_TARGET_GENES, MIR1250_3P, MIR4276, GSE14308_TH2_VS_TH1_DN, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, GSE15767_MED_VS_SCS_MAC_LN_UP, DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (7): outer dense fiber (GO:0001520), cytoplasm (GO:0005737), cytoplasmic vesicle (GO:0031410), sperm flagellum (GO:0036126), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
binding1
sperm flagellum1
polymeric cytoskeletal fiber1
intracellular anatomical structure1
cytoplasm1
intracellular vesicle1
9+2 motile cilium1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
cilium1

Protein interactions and networks

STRING

336 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FLACC1CATSPERTQ53TS8511
FLACC1ZNF404Q494X3480
FLACC1ATP6AP1LQ52LC2476
FLACC1TRAK2O60296448
FLACC1LRRC37A2A6NM11445
FLACC1LRRC37AA6NMS7444
FLACC1LRRC37A3O60309434
FLACC1ZNF155Q12901431
FLACC1CASP8Q14790419
FLACC1PLEKHD1A6NEE1404
FLACC1RCCD1A6NED2396
FLACC1BABAM1Q9NWV8391
FLACC1ANKRD34AQ69YU3372
FLACC1ABHD8Q96I13371
FLACC1PPIL3Q9H2H8371

IntAct

24 interactions, top by confidence:

ABTypeScore
SULT2B1FLACC1psi-mi:“MI:0915”(physical association)0.760
FLACC1SULT2B1psi-mi:“MI:0915”(physical association)0.760
FLACC1STK16psi-mi:“MI:0915”(physical association)0.560
TCL1AFLACC1psi-mi:“MI:0915”(physical association)0.560
TXNDC5FLACC1psi-mi:“MI:0915”(physical association)0.560
FLACC1TCL1Apsi-mi:“MI:0915”(physical association)0.560
FLACC1TXNDC5psi-mi:“MI:0915”(physical association)0.560
FLACC1SRCpsi-mi:“MI:0915”(physical association)0.400
FLACC1PIK3R1psi-mi:“MI:0915”(physical association)0.400
FLACC1SPTAN1psi-mi:“MI:0915”(physical association)0.400
FLACC1CLTApsi-mi:“MI:0915”(physical association)0.400
FLACC1MTUS2psi-mi:“MI:0915”(physical association)0.370
FLACC1SNX3psi-mi:“MI:0914”(association)0.350

BioGRID (42): ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), SULT2B1 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid), ALS2CR12 (Two-hybrid)

ESM2 similar proteins: A1L3H4, A5A777, A6H754, A7YY97, A9ULR1, B2GV52, C7GUN6, D3ZNV2, P05531, P0CAP1, P33716, P57679, P70281, Q03954, Q0IHJ3, Q28HY7, Q32L59, Q3UIJ9, Q4R764, Q4V9P3, Q58CS6, Q5EB94, Q5I0J4, Q5RA87, Q5XIC3, Q5ZK77, Q60547, Q60595, Q61806, Q63520, Q640Z7, Q6AY08, Q6CQ94, Q6NPG7, Q6P205, Q7L3B6, Q80Y56, Q810N9, Q8BXX9, Q8GYM3

Diamond homologs: Q6AY08, Q8BVM7, Q96Q35

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

80 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance63
Likely benign9
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2198 predictions. Top by Δscore:

VariantEffectΔscore
2:201288782:C:CCacceptor_gain1.0000
2:201289428:A:ACdonor_gain1.0000
2:201289429:G:Cdonor_gain1.0000
2:201289455:A:ACdonor_gain1.0000
2:201289456:C:CCdonor_gain1.0000
2:201289458:T:TAdonor_gain1.0000
2:201289475:T:TAdonor_gain1.0000
2:201289691:CTCA:Cdonor_loss1.0000
2:201289692:TCAC:Tdonor_loss1.0000
2:201289693:CA:Cdonor_loss1.0000
2:201289695:CCT:Cdonor_gain1.0000
2:201307514:GTTA:Gdonor_loss1.0000
2:201307515:TTAC:Tdonor_loss1.0000
2:201307516:TAC:Tdonor_loss1.0000
2:201307517:AC:Adonor_loss1.0000
2:201307518:C:Adonor_loss1.0000
2:201307520:T:TAdonor_gain1.0000
2:201307623:C:CCacceptor_gain1.0000
2:201309143:GTACT:Gdonor_loss1.0000
2:201309147:TCACT:Tdonor_loss1.0000
2:201309148:CACTT:Cdonor_loss1.0000
2:201309149:A:ACdonor_gain1.0000
2:201309149:ACTTT:Adonor_loss1.0000
2:201309150:C:CAdonor_gain1.0000
2:201309150:CT:Cdonor_gain1.0000
2:201309150:CTTT:Cdonor_gain1.0000
2:201309150:CTTTG:Cdonor_gain1.0000
2:201309246:CTGTC:Cacceptor_gain1.0000
2:201330739:G:Cdonor_gain1.0000
2:201344163:CACT:Cdonor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000037238 (2:201324842 G>A), RS1000096649 (2:201302455 A>G), RS1000104899 (2:201332172 T>C), RS1000200445 (2:201312296 T>A), RS1000211649 (2:201359608 T>C), RS1000228137 (2:201304914 T>C), RS1000280238 (2:201305092 A>T), RS1000295416 (2:201352621 T>G), RS1000376154 (2:201339277 T>C), RS1000391532 (2:201291134 C>T), RS1000470905 (2:201330182 G>A), RS1000523009 (2:201330459 G>A,C,T), RS1000551051 (2:201348500 C>T), RS1000558840 (2:201302582 T>C), RS1000694243 (2:201291886 C>G,T)

Disease associations

OMIM: gene MIM:619796 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

17 associations (top):

StudyTraitp-value
GCST002568_7Esophageal squamous cell carcinoma4.000000e-13
GCST002842_11Basal cell carcinoma2.000000e-09
GCST003726_11Basal cell carcinoma7.000000e-19
GCST004607_249Plateletcrit1.000000e-09
GCST004632_137Lymphocyte percentage of white cells1.000000e-12
GCST004633_110Neutrophil percentage of white cells7.000000e-12
GCST004988_16Breast cancer2.000000e-16
GCST005896_50Non-melanoma skin cancer2.000000e-13
GCST008870_5Keratinocyte cancer (MTAG)2.000000e-48
GCST008871_65Basal cell carcinoma5.000000e-55
GCST008872_6Squamous cell carcinoma2.000000e-07
GCST010148_4Cutaneous squamous cell carcinoma3.000000e-09
GCST010244_357Triglyceride levels4.000000e-08
GCST011011_53Youthful appearance (self-reported)2.000000e-09
GCST90002388_307Lymphocyte count1.000000e-40
GCST90002389_135Lymphocyte percentage of white cells1.000000e-19
GCST90002402_285Platelet count1.000000e-18

EFO canonical traits (9, from GWAS)

EFO IDTrait name
EFO:0007985platelet crit
EFO:0007993lymphocyte percentage of leukocytes
EFO:0007990neutrophil percentage of leukocytes
EFO:0009260non-melanoma skin carcinoma
EFO:0010176keratinocyte carcinoma
EFO:1001927cutaneous squamous cell carcinoma
EFO:0004530triglyceride measurement
EFO:0004587lymphocyte count
EFO:0004309platelet count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
Smokedecreases expression, increases abundance, increases expression2
aristolochic acid Iincreases expression1
sotorasibdecreases expression, affects cotreatment1
triphenyl phosphateaffects expression1
trichostatin Aaffects expression1
perfluorooctane sulfonic aciddecreases expression1
CGP 52608affects binding, increases reaction1
trametinibaffects cotreatment, decreases expression1
(+)-JQ1 compoundincreases expression1
NVP-BKM120affects cotreatment, decreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression1
Cisplatinincreases expression1
Doxorubicindecreases expression1
Tobacco Smoke Pollutiondecreases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_E1QCHAP1 ALS2CR12 (-)Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.